Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: MCsweet who wrote (1172)	11/2/2003 2:57:30 PM
From: Tomato	Read Replies (2) \| Respond to of 1833

My previous hopes of seeing a $3 stock are deflating as I think more about dilution. I don't know that Carl has a history of buying successful growth companies, and at 33 with what I assume is little experience, I don't know that our CEO is likely to pick a great company to buy. If selling all the assets would net SH $2 or more, how can the BOD justify a purchase that would cause dilution and a resulting share price under the value of $2/sh? Or maybe I'm underestimating the acumen of the Powers That Be and the announcement of a merger will cause the share price to soar over $2/sh and the price of new shares to exceed $2? Any thoughts on what will happen? Any historical examples out there?